Distribution of peripheral blood mononuclear cell subtypes in patients with West syndrome: Impact of synacthen treatment
- 17 July 2023
- journal article
- research article
- Published by Elsevier in Immunology Letters
- Vol. 261, 17-24
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Basic mechanisms of catastrophic epilepsy – Overview from animal modelsBrain and Development, 2013
- Peripheral lymphocyte subset and serum cytokine profiles of patients with West syndromeBrain and Development, 2010
- Increased Risk of Death Among Children With Lennox-Gastaut Syndrome and Infantile SpasmsJournal of Child Neurology, 2009
- A pilot study on the changes in immunity after ACTH therapy in patients with West syndromeBrain and Development, 2009
- A new trial liposteroid (dexamethasone palmitate) therapy for intractable epileptic seizures in infancyBrain and Development, 2007
- Current Treatment of West Syndrome in JapanJournal of Child Neurology, 2007
- Basic Fibroblast Growth Factor (bFGF, FGF-2) Potentiates Leukocyte Recruitment to Inflammation by Enhancing Endothelial Adhesion Molecule ExpressionThe American Journal of Pathology, 2006
- Cerebrospinal fluid interleukin-6 levels in patients with west syndromeBrain and Development, 2006
- The balance of inhibitory and excitatory cytokines is differently regulated in vivo and in vitro among therapy resistant epilepsy patientsEpilepsy Research, 2004
- What is West syndrome?Brain and Development, 2001